EUVIMEDEUVIMED entdecken
Crossref

EE78 FIRST-YEAR COST PER RESPONDER FOR BRODALUMAB COMPARED WITH OTHER BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA

Julie Poulin, Martin Barbeau

Value in Health · 2026-06 · 29 (6) · S77

DOI: 10.1016/j.jval.2026.03.307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Julie Poulin und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Poulin, J., & Barbeau, M. (2026). EE78 FIRST-YEAR COST PER RESPONDER FOR BRODALUMAB COMPARED WITH OTHER BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA. Value in Health, 29(6), S77. https://doi.org/10.1016/j.jval.2026.03.307

Vancouver

Poulin J, Barbeau M. EE78 FIRST-YEAR COST PER RESPONDER FOR BRODALUMAB COMPARED WITH OTHER BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA. Value in Health. 2026;29(6):S77. doi:10.1016/j.jval.2026.03.307

BibTeX
@article{Poulin2026,
  author = {Poulin, Julie and Barbeau, Martin},
  title = {EE78 FIRST-YEAR COST PER RESPONDER FOR BRODALUMAB COMPARED WITH OTHER BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {S77},
  doi = {10.1016/j.jval.2026.03.307}
}
Kostenlos starten →